Gene therapy for human colorectal carcinoma using human CEA promoter controled bacterial ADP-ribosylating toxin genes: PEA and DTA gene transfer

doi:10.3748/wjg.v4.i5.388

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2445)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

229

HTML

1848

Figures (1-2)

200

Tables (1-1)

168

Sum=2445

Oct 15, 1998 (publication date) through May 27, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Articles

World J Gastroenterol. Oct 15, 1998; 4(5): 388-391
Published online Oct 15, 1998. doi: 10.3748/wjg.v4.i5.388

Full Size Figure Download Figure

Figure 1 Structure of the retroviral constructs. LTR: long terminal repeat region; Neo: neomycin resistance gene; CMV: human cytomegalovirus immediate early promoter; CEA: human carcinoembryonic antigen promoter; PEA: Pseudomonas exotoxin domain II + III fragment; DTA: diphtheria toxin A.

Citation: Cao GW, Qi ZT, Pan X, Zhang XQ, Miao XH, Feng Y, Lu XH, Shigeki K, Ping D. Gene therapy for human colorectal carcinoma using human CEA promoter controled bacterial ADP-ribosylating toxin genes: PEA and DTA gene transfer. World J Gastroenterol 1998; 4(5): 388-391
URL: https://www.wjgnet.com/1007-9327/full/v4/i5/388.htm
DOI: https://dx.doi.org/10.3748/wjg.v4.i5.388